12/20/2022

Notice of COVID-19 infection of our employees and suspension of telephone reception

11/29/2022

FY2022 Q3 Analyst Call Q&A Summary

08/25/2022

FY2022 Q2 Analyst Call Q&A Summary

06/11/2022

Chief Scientific Officer of Cullgen Inc. will be speaking at the 30th Annual Meeting of the Japanese Breast Cancer Society

06/11/2022

Beijing Continent enrolls the first subject of pirfenidone capsules Phase III clinical trial for pneumoconiosis

05/24/2022

FY2022 Q1 Analyst Call Q&A Summary

04/15/2022

GNI Group FY2021 Annual General Meeting Q&A Summary

01/31/2022

Frequently Asked Questions Updated File (2022-JAN-31)

01/31/2022

Frequently Asked Questions Updated (2022-JAN-31)

01/04/2022

2022 New Year Greeting